Wahana Interfood Nusantara
COCO
$48.39
-5.12%
The Vita Coco Company is a leading plant-based functional hydration platform operating in the non-alcoholic beverage industry. It is defined by its flagship Vita Coco Coconut Water brand and positions itself as a growth-oriented player leveraging the health and wellness trend.
COCO
Wahana Interfood Nusantara
$48.39
Investment Opinion: Should I buy COCO Today?
Based on a synthesis of the available data, the objective assessment is a Hold. The stock's valuation has become more reasonable after the correction, and its strong financial health is a positive. However, the recent deterioration in profitability metrics and lack of revenue momentum create significant near-term uncertainty. Investors should wait for clearer signs of a growth re-acceleration or further price consolidation before establishing new positions.
Sign up to view all
COCO 12-Month Price Forecast
The analysis leans neutral due to conflicting signals: excellent financial health vs. deteriorating near-term fundamentals. The high probability base case reflects a belief that the strong balance sheet will prevent a crash, but growth concerns will cap upside in the near term.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Wahana Interfood Nusantara's 12-month outlook, with a consensus price target around $62.91 and implied upside of +30.0% versus the current price.
Average Target
$62.91
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$39 - $63
Analyst target range
Analyst consensus data, including a target price and ratings distribution, is not available in the provided inputs. The available data shows only one analyst providing estimates for future EPS and revenue, with an estimated EPS of $2.53 and revenue of $1.03 billion. Recent institutional rating actions from 2024 show a mix of 'Overweight/Buy' and 'Neutral' ratings, but no current consensus summary or price target is provided for analysis as of the current date.
Bulls vs Bears: COCO Investment Factors
COCO presents a mixed picture. The company has a fortress-like balance sheet and strong operational returns, but is grappling with slowing growth and volatile earnings. The recent sharp sell-off has improved the forward valuation, but the stock remains highly sensitive to near-term execution.
Bullish
- Strong Balance Sheet: Very low debt-to-equity of 0.04 and high current ratio of 3.62 provide financial stability.
- High Return on Equity: ROE of 21.5% indicates efficient use of shareholder capital.
- Attractive Forward Valuation: Forward P/E of 24.3 is more reasonable than the trailing P/E of 42.3.
- Positioned in Growth Trend: Operates in plant-based functional hydration, aligning with health and wellness.
Bearish
- Stalling Revenue Growth: Q4 revenue grew only 0.39% YoY, indicating potential market saturation.
- Volatile Profitability: Net margin dropped from 13.2% in Q3 to 4.3% in Q4, showing inconsistency.
- High Trailing Valuation: Trailing P/E of 42.3 and P/S of 4.95 are elevated for modest growth.
- Recent Sharp Underperformance: Stock down ~20% in one month, significantly underperforming the SPY.
COCO Technical Analysis
The stock has experienced significant volatility over the past six months, with a strong rally from October 2025 into early 2026, followed by a sharp recent correction. The price climbed from around $42 in October 2025 to a peak near $61 in March 2026, but has since retreated sharply. Short-term performance shows a substantial decline, with the stock down 19.88% over the past month and 12.93% over the past three months, significantly underperforming the broader market (SPY down 7.87% and 7.32%, respectively). The current price of $46.52 is near the lower end of its 52-week range of $25.79 to $61.39, representing a drawdown of approximately 24% from its recent high.
Beta
0.47
0.47x market volatility
Max Drawdown
-25.5%
Largest decline past year
52-Week Range
$30-$61
Price range past year
Annual Return
+56.6%
Cumulative gain past year
| Period | COCO Return | S&P 500 |
|---|---|---|
| 1m | -17.1% | +3.6% |
| 3m | -12.5% | -1.1% |
| 6m | +21.1% | +3.1% |
| 1y | +56.6% | +28.5% |
| ytd | -9.5% | +0.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COCO Fundamental Analysis
Revenue growth has been modest, with Q4 2025 revenue of $127.8 million showing minimal year-over-year growth of 0.39%. Profitability metrics have been volatile; the Q4 2025 net margin was 4.3%, a significant drop from the 13.2% net margin in Q3 2025, indicating potential seasonal or cost pressures. The company maintains a strong financial position with a very low debt-to-equity ratio of 0.039 and a robust current ratio of 3.62, supported by substantial cash holdings. Operational efficiency is mixed, with a strong Return on Equity (ROE) of 21.5% but a trailing twelve-month free cash flow of $39.0 million, though quarterly cash flow from operations was negative in Q4 2025.
Quarterly Revenue
$127787000.0B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.34%
Latest Quarter
Free Cash Flow
$39025000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COCO Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is elevated at 42.3, while the forward P/E is 24.3 based on analyst estimates. The Price-to-Sales (P/S) ratio of 4.95 and EV-to-Sales of 4.06 provide additional context. The valuation appears high on a trailing earnings basis but more reasonable on a forward-looking basis, assuming the company meets its earnings growth targets. Data for a direct peer comparison with industry averages is not available in the provided inputs.
PE
42.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -69x~155x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.8x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is operational execution, as evidenced by the steep quarterly decline in net margin from 13.2% to 4.3%, which could signal rising input costs or competitive pricing pressures. Slowing top-line growth (0.39% YoY in Q4) adds to concerns about the company's ability to scale profitably in a competitive beverage market. Market risk is elevated, with the stock showing high volatility (beta of 0.36 suggests low correlation but recent drawdown is severe) and significant underperformance versus the broader market over the past month. Liquidity and financial risks are low given the strong balance sheet, but business model risk exists if the health and wellness trend supporting coconut water demand wanes. The lack of a broad analyst consensus further increases information asymmetry and price risk for investors.
FAQ
The key risks are: 1) Execution Risk: Profitability collapsed from a 13.2% net margin in Q3 to 4.3% in Q4, indicating potential cost or pricing issues. 2) Growth Risk: Revenue growth has nearly stalled (0.39% YoY). 3) Valuation Risk: High multiples require sustained growth to justify. 4) Market Risk: The stock has high volatility and recently underperformed the SPY by over 12% in three months.
The 12-month outlook is for range-bound trading with a neutral bias. The base case (55% probability) sees the stock trading between $46 and $55, anchored by its forward P/E and current price level. A bull case (25%) could see a rally back to $58-$61 if execution improves, while a bear case (20%) could see a decline to $35-$42 if growth stalls further. The lack of a broad analyst consensus adds uncertainty to any forecast.
COCO's valuation is mixed. It appears overvalued based on trailing earnings (P/E of 42.3) given its current growth rate. However, it looks more reasonably valued on a forward basis (P/E of 24.3) if it meets the analyst EPS estimate of $2.53. The high Price-to-Sales ratio of 4.95 suggests the market still prices in future growth. Overall, it is fairly valued to slightly overvalued relative to its near-term fundamentals.
Based on current data, COCO is not a compelling buy for most investors. While its strong balance sheet (debt-to-equity of 0.04) is positive, the stock carries a high forward P/E of 24.3 despite showing minimal revenue growth (0.39% in Q4) and volatile profitability. The recent 20% monthly decline suggests the market is pricing in these concerns. A 'Hold' or 'Watchlist' stance is more appropriate until growth re-accelerates.
COCO is more suitable for a long-term investment horizon. Its strong brand and balance sheet are long-term assets, but the company is in a transitional phase with volatile quarterly results, making short-term price movements unpredictable. Long-term investors can look past near-term volatility, while short-term traders face significant risk from earnings surprises and the stock's recent high volatility.